Clinical Trial Update: Varenicline for Gait and Balance Impairment in Parkinson Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update of varenicline for gait and balance impairment in Parkinson disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Rush University Medical Center | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-12-30